Cargando…

Indolethylamine-N-methyltransferase Polymorphisms: Genetic and Biochemical Approaches for Study of Endogenous N,N,-dimethyltryptamine

N,N-dimethyltryptamine (DMT) is a powerful serotonergic psychedelic whose exogenous administration elicits striking psychedelic effects in humans. Studies have identified DMT and analogous compounds (e.g., 5-hydroxy-DMT, 5-methoxy-DMT) alongside of an enzyme capable of synthesizing DMT endogenously...

Descripción completa

Detalles Bibliográficos
Autor principal:	Dean, Jon G.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2018
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5924808/ https://www.ncbi.nlm.nih.gov/pubmed/29740267 http://dx.doi.org/10.3389/fnins.2018.00232

Ejemplares similares

Noncompetitive Inhibition of Indolethylamine-N-methyltransferase by N,N-Dimethyltryptamine and N,N-Dimethylaminopropyltryptamine
por: Chu, Uyen B., et al.
Publicado: (2014)

Indolethylamine N-methyltransferase (INMT) is not essential for endogenous tryptamine-dependent methylation activity in rats
por: Glynos, Nicolas G., et al.
Publicado: (2023)

N, N-Dimethyltryptamine (DMT), an Endogenous Hallucinogen: Past, Present, and Future Research to Determine Its Role and Function
por: Barker, Steven A.
Publicado: (2018)

Pharmacokinetics of N,N-dimethyltryptamine in Humans
por: Good, Meghan, et al.
Publicado: (2023)

Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT
por: Barker, Steven A.
Publicado: (2022)

Biosynthesis and Extracellular Concentrations of N,N-dimethyltryptamine (DMT) in Mammalian Brain
por: Dean, Jon G., et al.
Publicado: (2019)

A cane toad (Rhinella marina) N-methyltransferase converts primary indolethylamines to tertiary psychedelic amines
por: Chen, Xue, et al.
Publicado: (2023)

Indolethylamine-N-Methyltransferase Inhibits Proliferation and Promotes Apoptosis of Human Prostate Cancer Cells: A Mechanistic Exploration
por: Jianfeng, Wang, et al.
Publicado: (2022)

N,N‐dimethyltryptamine and Amazonian ayahuasca plant medicine
por: James, Edward, et al.
Publicado: (2022)

Phenomenology and content of the inhaled N, N-dimethyltryptamine (N, N-DMT) experience
por: Lawrence, David Wyndham, et al.
Publicado: (2022)

Reaction of N,N-Dimethyltryptamine with Dichloromethane Under Common Experimental Conditions
por: Dunlap, Lee E., et al.
Publicado: (2018)

Psychedelic N,N-Dimethyltryptamine and 5-Methoxy-N,N-Dimethyltryptamine Modulate Innate and Adaptive Inflammatory Responses through the Sigma-1 Receptor of Human Monocyte-Derived Dendritic Cells
por: Szabo, Attila, et al.
Publicado: (2014)

The Endogenous Hallucinogen and Trace Amine N,N-Dimethyltryptamine (DMT) Displays Potent Protective Effects against Hypoxia via Sigma-1 Receptor Activation in Human Primary iPSC-Derived Cortical Neurons and Microglia-Like Immune Cells
por: Szabo, Attila, et al.
Publicado: (2016)

N,N-dimethyltryptamine compound found in the hallucinogenic tea ayahuasca, regulates adult neurogenesis in vitro and in vivo
por: Morales-Garcia, Jose A., et al.
Publicado: (2020)

Population pharmacokinetic/pharmacodynamic modeling of the psychedelic experience induced by N,N‐dimethyltryptamine – Implications for dose considerations
por: Eckernäs, Emma, et al.
Publicado: (2022)

Detection and Quantification of Psychoactive N,N-Dimethyltryptamine in Ayahuasca Brews by Ambient Ionization High-Resolution Mass Spectrometry
por: Chambers, Megan I., et al.
Publicado: (2020)

The clinical pharmacology and potential therapeutic applications of 5‐methoxy‐N,N‐dimethyltryptamine (5‐MeO‐DMT)
por: Reckweg, Johannes T., et al.
Publicado: (2022)

Toxicokinetics and Toxicodynamics of Ayahuasca Alkaloids N,N-Dimethyltryptamine (DMT), Harmine, Harmaline and Tetrahydroharmine: Clinical and Forensic Impact
por: Brito-da-Costa, Andreia Machado, et al.
Publicado: (2020)

Chronic, Intermittent Microdoses of the Psychedelic N,N-Dimethyltryptamine (DMT) Produce Positive Effects on Mood and Anxiety in Rodents
por: Cameron, Lindsay P., et al.
Publicado: (2019)

N,N‐dimethyltryptamine affects electroencephalography response in a concentration‐dependent manner—A pharmacokinetic/pharmacodynamic analysis
por: Eckernäs, Emma, et al.
Publicado: (2023)

Enlightening the “Spirit Molecule”: Photomodulation of the 5‐HT(2A) Receptor by a Light‐Controllable N,N‐Dimethyltryptamine Derivative
por: Gerwe, Hubert, et al.
Publicado: (2022)

Optimized infusion rates for N,N‐dimethyltryptamine to achieve a target psychedelic intensity based on a modeling and simulation framework
por: Eckernäs, Emma, et al.
Publicado: (2023)

Fast Hollow Fiber Liquid-Phase Microextraction as a Greener Alternative for the Determination of N,N-Dimethyltryptamine and Harmala Alkaloids in Human Urine
por: Silveira, Gabriela de Oliveira, et al.
Publicado: (2020)

Prospective examination of synthetic 5-methoxy-N,N-dimethyltryptamine inhalation: effects on salivary IL-6, cortisol levels, affect, and non-judgment
por: Uthaug, Malin V, et al.
Publicado: (2019)

Dimethyltryptamine (DMT): a biochemical Swiss Army knife in neuroinflammation and neuroprotection?
por: Szabo, Attila, et al.
Publicado: (2016)

Reactivations after 5-methoxy-N,N-dimethyltryptamine use in naturalistic settings: An initial exploratory analysis of the phenomenon’s predictors and its emotional valence
por: Ortiz Bernal, Ana María, et al.
Publicado: (2022)

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N, N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers
por: Reckweg, Johannes, et al.
Publicado: (2021)

Biochemical and Computational Analysis of the Substrate Specificities of Cfr and RlmN Methyltransferases
por: Ntokou, Eleni, et al.
Publicado: (2015)

A Phase 1, Dose-Ranging Study to Assess Safety and Psychoactive Effects of a Vaporized 5-Methoxy-N,N-Dimethyltryptamine Formulation (GH001) in Healthy Volunteers
por: Reckweg, J., et al.
Publicado: (2022)

A phase 1/2 trial to assess safety and efficacy of a vaporized 5-methoxy-N,N-dimethyltryptamine formulation (GH001) in patients with treatment-resistant depression
por: Reckweg, Johannes T., et al.
Publicado: (2023)

Acute Intoxication following Dimethyltryptamine Ingestion
por: Bilhimer, Matthew H., et al.
Publicado: (2018)

Genetic Polymorphisms of the Glycine N-Methyltransferase and Prostate Cancer Risk in the Health Professionals Follow-Up Study
por: Chen, Marcelo, et al.
Publicado: (2014)

Physiological Study on Association between Nicotinamide N-Methyltransferase Gene Polymorphisms and Hyperlipidemia
por: Zhu, Xiao-Juan, et al.
Publicado: (2016)

Biochemical and genetic analysis of RNA cap guanine-N2 methyltransferases from Giardia lamblia and Schizosaccharomyces pombe
por: Hausmann, Stéphane, et al.
Publicado: (2007)

Histamine N-Methyltransferase in the Brain
por: Yoshikawa, Takeo, et al.
Publicado: (2019)

Convergent Mechanistic Features between the Structurally Diverse N- and O-Methyltransferases: Glycine N-Methyltransferase and Catechol O-Methyltransferase
por: Zhang, Jianyu, et al.
Publicado: (2016)

Molecular Identification of Carnosine N-Methyltransferase as Chicken Histamine N-Methyltransferase-Like Protein (HNMT-Like)
por: Drozak, Jakub, et al.
Publicado: (2013)

Nicotinamide N-Methyltransferase in Health and Cancer
por: Ramsden, David B, et al.
Publicado: (2017)

Nicotinamide N-methyltransferase and liver diseases
por: Liang, Guangyu, et al.
Publicado: (2022)

Biochemical and structural characterization of a DNA N(6)-adenine methyltransferase from Helicobacter pylori
por: Ma, Bo, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_6plda65t360ad72o8kcnds3i1p